Companies
Takeda GmbH
Track this competitor Create a free account to be notified when it wins a contract.
Contracts won 3
Amount won alone €216,001 excl. VAT
Shared contracts 1 (multi-supplier framework agreements)
Period 31 July 2026 – 29 September 2026
Where and what
Supplies · 3
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
Planned end Contract Current holder Amount
31 August 2028 re-tender around March 2028
Arzneimittelrabattvertrag zu den Arzneimitteln Advate (B02BD02),Recombinate (B02BD02),Rixubis (B02BD04),Feiba (B02BD03),Immunate (B02BD06),Immuseven (B02BD05),Adynovi (B02BD02),Veyvondi (B02BD10)
AOK Sachsen - Anhalt
Takeda GmbH 1 bid received
€1
31 August 2028 re-tender around March 2028
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V über 9 Präparate zur Behandlung der Hämophilie
AOK Baden-Württemberg framework agreement
Takeda GmbH 1 bid received
€216,000
31 December 2028 re-tender around July 2028
Arzneimittelausschreibung 2026_vergebene Aufträge
IKK classic
BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH) BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft) Dexcel Pharma GmbH Glenmark Arzneimittel GmbH neuraxpharm Arzneimittel GmbH Zentiva Pharma GmbH BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) Bluefish Pharma GmbH HEC Pharm GmbH Hormosan Pharma GmbH Holsten Pharma GmbH Viatris Healthcare GmbH PUREN Pharma GmbH & Co. KG Amarox Pharma GmbH BG Neuraxpharm / Hexal GbR (H e x a l Aktiengesellschaft, neuraxpharm Arzneimittel GmbH) BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH) HIKMA PHARMA GMBH 089Pharm GmbH Macleods Pharma Espana S.L.U. Klinge Pharma GmbH Micro Labs GmbH Medical Valley Invest AB ETHYPHARM GmbH Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH Basics GmbH Aristo Pharma GmbH Recordati Rare Diseases Germany GmbH axunio Pharma GmbH Hormosan Pharma Gesellschaft mit b 17 bids received
€224,584,123
Contracts won
Date Contract Buyer Amount
29/09/2026
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V über 9 Präparate zur Behandlung der Hämophilie
AOK Baden-Württemberg
€216,000
03/09/2026
Arzneimittelrabattvertrag zu den Arzneimitteln Advate (B02BD02),Recombinate (B02BD02),Rixubis (B02BD04),Feiba (B02BD03),Immunate (B02BD06),Immuseven (B02BD05),Adynovi (B02BD02),Veyvondi (B02BD10)
AOK Sachsen - Anhalt
€1
31/07/2026
Arzneimittelausschreibung 2026_vergebene Aufträge
IKK classic
€224,584,123shared by 67
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.